0
Articles |

Ventilation/Perfusion Ratios in Pulmonary Arterial Hypertension*: Effects of IV and Inhaled Prostacyclin Derivatives

Tomas Bratel, MD; Lars Lagerstrand, MD; Lars-Åke Brodin, MD; Jacek Nowak, MD; Ivar Randmaa, MD
Author and Funding Information

*From the Department of Pulmonary Diseases (Dr. Bratel), Karolinska Hospital, Karolinska; and Department of Clinical Physiology (Drs. Lagerstrand, Brodin, Nowak, and Randmaa), Huddinge University Hospital, Stockholm, Sweden.

Correspondence to: Tomas Bratel, MD, Department of Pulmonary Diseases, Karolinska Hospital, Karolinska, Sweden



Chest. 2005;128(6_suppl):615S-616S. doi:10.1378/chest.128.6_suppl.615S
Text Size: A A A
Published online

Extract

In nine patients with severe pulmonary arterial hypertension (one primary and the others secondary to systemic sclerosis or pulmonary embolism), ventilation/perfusion (V̇/Q̇) ratios were measured during right-heart catheterization using a multiple inert gas elimination technique. V̇/Q̇ ratios were assessed before and after administration of IV epoprostanol, 8.5 ± 1.8 ng/kg/min. Following 5.1 ± 1.5 months of inhaled iloprost therapy (20 μg tid), V̇/Q̇ ratios were again measured before and 15 min after inhalation of 20 μg of iloprost. Before treatment, mean (± SD) pulmonary artery pressure was 46.2 ± 13.5 mm Hg. Pulmonary vascular resistance (PVR) was 8.61 ± 4.52 mm Hg/L/min, and cardiac output was 4.22 ± 0.75 L/min. There was a moderately elevated shunt of 5.1% (range, 1.6 to 19.5%) of cardiac output and substantial high V̇/Q̇ ventilation of 8.1% of minute ventilation (range, 2.9 to 36.8%), and increased dispersion of perfusion and ventilation for the V̇/Q̇ ratios (SD of the distribution of perfusion [log SDQ], 0.93 ± 0.31; and SD of the distribution of ventilation, 08 ± 0.23). Epoprostanol infusion resulted in a 21 ± 18% reduction in PVR and a 36 ± 14% reduction in systemic vascular resistance. log SDQ was further increased by 30 ± 33%. The mean increase in shunt was approximately 60% higher during epoprostanol than after iloprost (p = 0.06). However, due to increased cardiac output and raised venous oxygen saturation (Svo2), Pao2 was not significantly altered.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543